Scott Drutman

1.3k total citations
12 papers, 256 citations indexed

About

Scott Drutman is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Scott Drutman has authored 12 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in Scott Drutman's work include Immunotherapy and Immune Responses (4 papers), Glycosylation and Glycoproteins Research (2 papers) and CAR-T cell therapy research (2 papers). Scott Drutman is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Glycosylation and Glycoproteins Research (2 papers) and CAR-T cell therapy research (2 papers). Scott Drutman collaborates with scholars based in United States, Australia and Spain. Scott Drutman's co-authors include E. Sergio Trombetta, Alice Yewdall, Keith S. Bahjat, Nina Bhardwaj, Keith R. Matthews, Marleen T. J. van Ampting, Marco A. Sánchez, Scott M. Landfear, David G. Pfister and Nora Katabi and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Scott Drutman

10 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Drutman United States 5 191 86 65 34 21 12 256
Christopher Paustian United States 8 152 0.8× 68 0.8× 97 1.5× 28 0.8× 14 0.7× 24 221
Philip A. Hull United States 6 91 0.5× 134 1.6× 45 0.7× 43 1.3× 38 1.8× 6 301
Elena Bruni Italy 7 225 1.2× 39 0.5× 85 1.3× 39 1.1× 15 0.7× 9 299
Edwin Widyanto Daniwijaya Indonesia 6 122 0.6× 53 0.6× 40 0.6× 10 0.3× 40 1.9× 13 212
Huifang Xian China 8 144 0.8× 182 2.1× 40 0.6× 86 2.5× 25 1.2× 9 292
Adam Shahine Australia 11 266 1.4× 71 0.8× 90 1.4× 46 1.4× 43 2.0× 24 362
Daphné Laubreton France 10 111 0.6× 97 1.1× 39 0.6× 77 2.3× 28 1.3× 18 267
Li Zhong China 8 216 1.1× 203 2.4× 55 0.8× 40 1.2× 63 3.0× 15 323
François Asperti-Boursin France 7 198 1.0× 59 0.7× 83 1.3× 46 1.4× 11 0.5× 9 294
Curtis J. Pritzl United States 10 218 1.1× 158 1.8× 48 0.7× 101 3.0× 46 2.2× 12 344

Countries citing papers authored by Scott Drutman

Since Specialization
Citations

This map shows the geographic impact of Scott Drutman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Drutman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Drutman more than expected).

Fields of papers citing papers by Scott Drutman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Drutman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Drutman. The network helps show where Scott Drutman may publish in the future.

Co-authorship network of co-authors of Scott Drutman

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Drutman. A scholar is included among the top collaborators of Scott Drutman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Drutman. Scott Drutman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Dumbrava, Ecaterina E., Cara Mathews, Bert H. O’Neil, et al.. (2025). Preliminary results from a first-in-human, phase I/II study of VLS-1488, an oral KIF18A inhibitor, in patients with advanced solid tumors.. Journal of Clinical Oncology. 43(16_suppl). 3012–3012.
2.
Gaillard, Stéphanie, Alexander Starodub, Bert H. O’Neil, et al.. (2024). A phase I/II, first-in-human study of VLS-1488, an oral KIF18A inhibitor, in patients with advanced cancer.. Journal of Clinical Oncology. 42(16_suppl). TPS3181–TPS3181. 1 indexed citations
3.
Zhang, Rumin, Akanksha Verma, Tamar Y. Feinberg, et al.. (2023). Abstract 517: Targeting chromosomally unstable tumors with a selective KIF18A inhibitor. Cancer Research. 83(7_Supplement). 517–517. 1 indexed citations
4.
Burman, Bharat, Scott Drutman, Matthew G. Fury, et al.. (2022). Pharmacodynamic and therapeutic pilot studies of single-agent ribavirin in patients with human papillomavirus–related malignancies. Oral Oncology. 128. 105806–105806. 9 indexed citations
5.
Zhang, Rumin, Derek A. Cogan, Tamar Y. Feinberg, et al.. (2022). Discovery of potent, orally active KIF18A inhibitors targeting CIN-high cancer cells.. Journal of Clinical Oncology. 40(16_suppl). e15046–e15046. 2 indexed citations
6.
Rischin, Danny, Brett Hughes, Nicole Basset‐Séguin, et al.. (2021). 1066P Extended-dose cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Primary analysis of phase II results. Annals of Oncology. 32. S886–S887. 1 indexed citations
7.
Drutman, Scott, et al.. (2012). Inflammatory Spleen Monocytes Can Upregulate CD11c Expression Without Converting into Dendritic Cells. The Journal of Immunology. 188(8). 3603–3610. 33 indexed citations
8.
Sanchez, Miguel & Scott Drutman. (2012). Current topics in infectious diseases of the skin. Expert Review of Dermatology. 7(1). 93–106. 1 indexed citations
9.
Yewdall, Alice, et al.. (2010). CD8+ T Cell Priming by Dendritic Cell Vaccines Requires Antigen Transfer to Endogenous Antigen Presenting Cells. PLoS ONE. 5(6). e11144–e11144. 111 indexed citations
10.
Drutman, Scott & E. Sergio Trombetta. (2010). Dendritic Cells Continue To Capture and Present Antigens after Maturation In Vivo. The Journal of Immunology. 185(4). 2140–2146. 69 indexed citations
11.
Drutman, Scott, et al.. (2005). A truncated acidic domain in Xenopus TRF1. Gene. 369. 20–26. 4 indexed citations
12.
Sánchez, Marco A., Scott Drutman, Marleen T. J. van Ampting, Keith R. Matthews, & Scott M. Landfear. (2004). A novel purine nucleoside transporter whose expression is up-regulated in the short stumpy form of the Trypanosoma brucei life cycle. Molecular and Biochemical Parasitology. 136(2). 265–272. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Paustian Breakdown of academic impact, for papers by Philip A. Hull Breakdown of academic impact, for papers by Elena Bruni Breakdown of academic impact, for papers by Edwin Widyanto Daniwijaya Breakdown of academic impact, for papers by Huifang Xian Breakdown of academic impact, for papers by Adam Shahine Breakdown of academic impact, for papers by Daphné Laubreton Breakdown of academic impact, for papers by Li Zhong Breakdown of academic impact, for papers by François Asperti-Boursin Breakdown of academic impact, for papers by Curtis J. Pritzl
Rankless by CCL
2026